doi: 10.1038/srep04362
TABLE 3 Factors associated with anxiety incidence in diabetes patients with/without GLP1-RA: subgroup analysis
Based on Phase 2 data, retatrutide produces substantially greater weight loss than semaglutide (Ozempic/Wegovy)
[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Miki T., Minami K., Shinozaki H., Matsumura K., Saraya A., Ikeda H., Yamada Y., Holst J.J., Seino S
Integrating retatrutide with complementary endocrine tools Because most endocrine and metabolic studies are designed around panels of interventions rather than single-agent experiments, the REDF program will also explore how Retatrutide can be positioned alongside other commonly used research tools such as growth-hormone secretagogues and appetite-modulating compounds
Diabetes Obes Metab 2020;22:631-9